why choose us

First received: July 31, 2023

Clinical Trial: Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hemophilia A

Study Type: INTERVENTIONAL


Official Title: A First-in-Human (FIH), Randomized, Double-Blind, Placebo-controlled, Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of TU7710 Following Single, Ascending, Intrave

Brief Summary: This is a Phase 1a, double-blind, randomized, placebo- controlled, SAD study to assess safety, tolerability, PK, and PD of TU7710 in warfarin treated healthy male participants.

Read more